Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 230 entries
Sorted by: Best Match Show Resources per page
When the labs closed: graduate students' and postdoctoral fellows' experiences of disrupted research during the COVID-19 pandemic

postdoctoral

Suart C.
GSID: _kwPG_fQW44J
C Suart, T Nowlan Suart, K Graham, R Truant - FACETS, 2021 - facetsjournal.com

Government imposed lockdown measures in response to the COVID-19 pandemic resulted in widespread laboratory closures. This study aimed to examine the impact of this disruption …

Cite
Suart, C., Nowlan Suart, T., Graham, K., & Truant, R. (2021). When the labs closed: graduate students’ and postdoctoral fellows’ experiences of disrupted research during the COVID-19 pandemic. FACETS, 6(1), 966-997.
Suart, Celeste, et al. "When the labs closed: graduate students’ and postdoctoral fellows’ experiences of disrupted research during the COVID-19 pandemic." FACETS 6.1 (2021): 966-997.
Copy Download .nbib Format: MLA
Prevalent Practices of Thyroid Diseases During Pregnancy Among Endocrinologists, Internists and General Practitioners.

International journal of endocrinology and metabolism

Azizi F, Mehran L, Amouzegar A, Alamdari S, Subetki I, Saadat N, Moini S, Sarvghadi F.
PMID: 27274337
Int J Endocrinol Metab. 2015 Nov 07;14(1):e29601. doi: 10.5812/ijem.29601. eCollection 2016 Jan.

BACKGROUND: Maternal thyroid disease in pregnancy is associated with adverse impact on both mother and fetus. Both the American thyroid association and the endocrine society have recently published guidelines for the management of thyroid disease in pregnancy.OBJECTIVES: The objective...

Cite
Azizi F, Mehran L, Amouzegar A, et al. Prevalent Practices of Thyroid Diseases During Pregnancy Among Endocrinologists, Internists and General Practitioners. Int J Endocrinol Metab. 2015;14(1):e29601doi: 10.5812/ijem.29601.
Azizi, F., Mehran, L., Amouzegar, A., Alamdari, S., Subetki, I., Saadat, N., Moini, S., & Sarvghadi, F. (2016). Prevalent Practices of Thyroid Diseases During Pregnancy Among Endocrinologists, Internists and General Practitioners. International journal of endocrinology and metabolism, 14(1), e29601. https://doi.org/10.5812/ijem.29601
Azizi, Fereidoun, et al. "Prevalent Practices of Thyroid Diseases During Pregnancy Among Endocrinologists, Internists and General Practitioners." International journal of endocrinology and metabolism vol. 14,1 (2016): e29601. doi: https://doi.org/10.5812/ijem.29601
Azizi F, Mehran L, Amouzegar A, Alamdari S, Subetki I, Saadat N, Moini S, Sarvghadi F. Prevalent Practices of Thyroid Diseases During Pregnancy Among Endocrinologists, Internists and General Practitioners. Int J Endocrinol Metab. 2015 Nov 07;14(1):e29601. doi: 10.5812/ijem.29601. eCollection 2016 Jan. PMID: 27274337; PMCID: PMC4894079.
Copy Download .nbib Format: NLM
Hepatitis e: molecular virology and pathogenesis.

Journal of clinical and experimental hepatology

Panda SK, Varma SP.
PMID: 25755485
J Clin Exp Hepatol. 2013 Jun;3(2):114-24. doi: 10.1016/j.jceh.2013.05.001. Epub 2013 May 30.

Hepatitis E virus is a single, positive-sense, capped and poly A tailed RNA virus classified under the family Hepeviridae. Enteric transmission, acute self-limiting hepatitis, frequent epidemic and sporadic occurrence, high mortality in affected pregnants are hallmarks of hepatitis E...

Cite
Panda SK, Varma SP. Hepatitis e: molecular virology and pathogenesis. J Clin Exp Hepatol. 2013;3(2):114-24doi: 10.1016/j.jceh.2013.05.001.
Panda, S. K., & Varma, S. P. (2013). Hepatitis e: molecular virology and pathogenesis. Journal of clinical and experimental hepatology, 3(2), 114-24. https://doi.org/10.1016/j.jceh.2013.05.001
Panda, Subrat K, and Varma, Satya P K. "Hepatitis e: molecular virology and pathogenesis." Journal of clinical and experimental hepatology vol. 3,2 (2013): 114-24. doi: https://doi.org/10.1016/j.jceh.2013.05.001
Panda SK, Varma SP. Hepatitis e: molecular virology and pathogenesis. J Clin Exp Hepatol. 2013 Jun;3(2):114-24. doi: 10.1016/j.jceh.2013.05.001. Epub 2013 May 30. PMID: 25755485; PMCID: PMC3940135.
Copy Download .nbib Format: NLM
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Journal of clinical and experimental hepatology

Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoorz D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Sarin SK, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M.
PMID: 25755548
J Clin Exp Hepatol. 2014 Jun;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. Epub 2014 Jun 09.

Globally, around 150 million people are infected with hepatitis C virus (HCV). India contributes a large proportion of this HCV burden. The prevalence of HCV infection in India is estimated at between 0.5% and 1.5%. It is higher in...

Cite
Puri P, Anand AC, Saraswat VA, et al. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol. 2014;4(2):106-16doi: 10.1016/j.jceh.2014.05.006.
Puri, P., Anand, A. C., Saraswat, V. A., Acharya, S. K., Dhiman, R. K., Aggarwal, R., Singh, S. P., Amarapurkar, D., Arora, A., Chhabra, M., Chetri, K., Choudhuri, G., Dixit, V. K., Duseja, A., Jain, A. K., Kapoorz, D., Kar, P., Koshy, A., Kumar, A., Madan, K., Misra, S. P., Prasad, M. V., Nagral, A., Puri, A. S., Jeyamani, R., Saigal, S., Sarin, S. K., Shah, S., Sharma, P. K., Sood, A., Thareja, S., & Wadhawan, M. (2014). Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. Journal of clinical and experimental hepatology, 4(2), 106-16. https://doi.org/10.1016/j.jceh.2014.05.006
Puri, Pankaj, et al. "Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India." Journal of clinical and experimental hepatology vol. 4,2 (2014): 106-16. doi: https://doi.org/10.1016/j.jceh.2014.05.006
Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoorz D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Sarin SK, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol. 2014 Jun;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. Epub 2014 Jun 09. PMID: 25755548; PMCID: PMC4116733.
Copy Download .nbib Format: NLM
Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Journal of clinical and experimental hepatology

Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS, Bhatia V, Sharma M, Kumar M, Gupta S, Taneja S, Kaman L, Zargar SA, Nundy S, Singh SP, Acharya SK, Dilawari JB.
PMID: 25755591
J Clin Exp Hepatol. 2014 Feb;4:S2-S14. doi: 10.1016/j.jceh.2014.02.003. Epub 2014 Feb 25.

Portal cavernoma cholangiopathy (PCC) is defined as abnormalities in the extrahepatic biliary system including the cystic duct and gallbladder with or without abnormalities in the 1st and 2nd generation biliary ducts in a patient with portal cavernoma. Presence of...

Cite
Dhiman RK, Saraswat VA, Valla DC, et al. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. J Clin Exp Hepatol. 2014;4:S2-S14doi: 10.1016/j.jceh.2014.02.003.
Dhiman, R. K., Saraswat, V. A., Valla, D. C., Chawla, Y., Behera, A., Varma, V., Agarwal, S., Duseja, A., Puri, P., Kalra, N., Rameshbabu, C. S., Bhatia, V., Sharma, M., Kumar, M., Gupta, S., Taneja, S., Kaman, L., Zargar, S. A., Nundy, S., Singh, S. P., Acharya, S. K., & Dilawari, J. B. (2014). Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. Journal of clinical and experimental hepatology, 4S2-S14. https://doi.org/10.1016/j.jceh.2014.02.003
Dhiman, Radha K, et al. "Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver." Journal of clinical and experimental hepatology vol. 4 (2014): S2-S14. doi: https://doi.org/10.1016/j.jceh.2014.02.003
Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS, Bhatia V, Sharma M, Kumar M, Gupta S, Taneja S, Kaman L, Zargar SA, Nundy S, Singh SP, Acharya SK, Dilawari JB. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. J Clin Exp Hepatol. 2014 Feb;4:S2-S14. doi: 10.1016/j.jceh.2014.02.003. Epub 2014 Feb 25. PMID: 25755591; PMCID: PMC4274351.
Copy Download .nbib Format: NLM
Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome.

Journal of clinical and experimental hepatology

Srivastava S, Shalimar, Vishnubhatla S, Prakash S, Sharma H, Thakur B, Acharya SK.
PMID: 26900268
J Clin Exp Hepatol. 2015 Dec;5(4):276-85. doi: 10.1016/j.jceh.2015.08.003. Epub 2015 Sep 01.

BACKGROUND: Terlipressin with albumin is recommended in hepatorenal syndrome (HRS). Terlipressin is expensive and not licensed in many countries. Alternative therapy is necessary. We compared the efficacy of terlipressin and albumin with concurrent low-dose dopamine, furosemide, and albumin in...

Cite
Srivastava S, Shalimar, Vishnubhatla S, et al. Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome. J Clin Exp Hepatol. 2015;5(4):276-85doi: 10.1016/j.jceh.2015.08.003.
Srivastava, S., Shalimar, Vishnubhatla, S., Prakash, S., Sharma, H., Thakur, B., & Acharya, S. K. (2015). Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome. Journal of clinical and experimental hepatology, 5(4), 276-85. https://doi.org/10.1016/j.jceh.2015.08.003
Srivastava, Siddharth, et al. "Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome." Journal of clinical and experimental hepatology vol. 5,4 (2015): 276-85. doi: https://doi.org/10.1016/j.jceh.2015.08.003
Srivastava S, Shalimar, Vishnubhatla S, Prakash S, Sharma H, Thakur B, Acharya SK. Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome. J Clin Exp Hepatol. 2015 Dec;5(4):276-85. doi: 10.1016/j.jceh.2015.08.003. Epub 2015 Sep 01. PMID: 26900268; PMCID: PMC4723649.
Copy Download .nbib Format: NLM
Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment.

Neoplasma

Dvorak P, Lysak D, Vokurka S, Karas M, Subrt I.
PMID: 25563378
Neoplasma. 2015;62(1):140-5. doi: 10.4149/neo_2015_018.

UNLABELLED: Our retrospective analysis was performed on 376 consecutive patients diagnosed with AML. A total of 256 (68%) were treated with standard "7+3" induction and high-dose cytarabine and mitoxantrone containing "4+3" consolidation/intensification regimens. Our study focused on patients with...

Cite
Dvorak P, Lysak D, Vokurka S, et al. Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment. Neoplasma. 2015;62(1):140-5doi: 10.4149/neo_2015_018.
Dvorak, P., Lysak, D., Vokurka, S., Karas, M., & Subrt, I. (2015). Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment. Neoplasma, 62(1), 140-5. https://doi.org/10.4149/neo_2015_018
Dvorak, P, et al. "Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment." Neoplasma vol. 62,1 (2015): 140-5. doi: https://doi.org/10.4149/neo_2015_018
Dvorak P, Lysak D, Vokurka S, Karas M, Subrt I. Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment. Neoplasma. 2015;62(1):140-5. doi: 10.4149/neo_2015_018. PMID: 25563378.
Copy Download .nbib Format: NLM
Waugh's Syndrome: Blessing in Disguise.

Journal of clinical and diagnostic research : JCDR

Behera CR, Mohanty SK.
PMID: 25478404
J Clin Diagn Res. 2014 Oct;8(10):ND26-7. doi: 10.7860/JCDR/2014/9557.5051. Epub 2014 Oct 20.

Waugh's syndrome is the association between intestinal malrotion and intussusceptions. We report a case of Waugh's syndrome in a one year old child who presented to us with acute bowel obstruction and bleeding per rectum. Due to malrotation, there...

Cite
Behera CR, Mohanty SK. Waugh's Syndrome: Blessing in Disguise. J Clin Diagn Res. 2014;8(10):ND26-7doi: 10.7860/JCDR/2014/9557.5051.
Behera, C. R., & Mohanty, S. K. (2014). Waugh's Syndrome: Blessing in Disguise. Journal of clinical and diagnostic research : JCDR, 8(10), ND26-7. https://doi.org/10.7860/JCDR/2014/9557.5051
Behera, Chinmaya Ranjan, and Mohanty, Subrat K. "Waugh's Syndrome: Blessing in Disguise." Journal of clinical and diagnostic research : JCDR vol. 8,10 (2014): ND26-7. doi: https://doi.org/10.7860/JCDR/2014/9557.5051
Behera CR, Mohanty SK. Waugh's Syndrome: Blessing in Disguise. J Clin Diagn Res. 2014 Oct;8(10):ND26-7. doi: 10.7860/JCDR/2014/9557.5051. Epub 2014 Oct 20. PMID: 25478404; PMCID: PMC4253222.
Copy Download .nbib Format: NLM
Microarray of non-connected gold pads used as high density electric traps for parallelized pairing and fusion of cells.

Biomicrofluidics

Hamdi FS, Français O, Subra F, Dufour-Gergam E, Le Pioufle B.
PMID: 24404035
Biomicrofluidics. 2013 Jul 03;7(4):44101. doi: 10.1063/1.4813062. eCollection 2013.

Cell fusion consists of inducing the formation of a hybridoma cell containing the genetic properties of the progenitor cells. Such an operation is usually performed chemically or electrically. The latter method, named electrofusion, is considered as having a strong...

Cite
Hamdi FS, Français O, Subra F, et al. Microarray of non-connected gold pads used as high density electric traps for parallelized pairing and fusion of cells. Biomicrofluidics. 2013;7(4):44101doi: 10.1063/1.4813062.
Hamdi, F. S., Français, O., Subra, F., Dufour-Gergam, E., & Le Pioufle, B. (2013). Microarray of non-connected gold pads used as high density electric traps for parallelized pairing and fusion of cells. Biomicrofluidics, 7(4), 44101. https://doi.org/10.1063/1.4813062
Hamdi, Feriel S, et al. "Microarray of non-connected gold pads used as high density electric traps for parallelized pairing and fusion of cells." Biomicrofluidics vol. 7,4 (2013): 44101. doi: https://doi.org/10.1063/1.4813062
Hamdi FS, Français O, Subra F, Dufour-Gergam E, Le Pioufle B. Microarray of non-connected gold pads used as high density electric traps for parallelized pairing and fusion of cells. Biomicrofluidics. 2013 Jul 03;7(4):44101. doi: 10.1063/1.4813062. eCollection 2013. PMID: 24404035; PMCID: PMC3716780.
Copy Download .nbib Format: NLM
Multicenter Study of Contraceptive Vaginal Ring (NuvaRing(®)) in Normal Daily Practice in Indian Women.

Journal of obstetrics and gynaecology of India

Pandit SN, Chauhan AR, Anagani M, Reddy S, Birla A, Ray SK.
PMID: 25489144
J Obstet Gynaecol India. 2014 Dec;64(6):409-16. doi: 10.1007/s13224-014-0559-7. Epub 2014 May 15.

OBJECTIVE: This was the first Indian multicenter study at six specialty hospitals, to assess the real-life usage of the vaginal ring in daily clinical practice.METHODS: This open-label, prospective, single-arm, nonrandomized, interventional study enrolled 252 women aged >18 years, seeking...

Cite
Pandit SN, Chauhan AR, Anagani M, et al. Multicenter Study of Contraceptive Vaginal Ring (NuvaRing(®)) in Normal Daily Practice in Indian Women. J Obstet Gynaecol India. 2014;64(6):409-16doi: 10.1007/s13224-014-0559-7.
Pandit, S. N., Chauhan, A. R., Anagani, M., Reddy, S., Birla, A., & Ray, S. K. (2014). Multicenter Study of Contraceptive Vaginal Ring (NuvaRing(®)) in Normal Daily Practice in Indian Women. Journal of obstetrics and gynaecology of India, 64(6), 409-16. https://doi.org/10.1007/s13224-014-0559-7
Pandit, Suchitra N, et al. "Multicenter Study of Contraceptive Vaginal Ring (NuvaRing(®)) in Normal Daily Practice in Indian Women." Journal of obstetrics and gynaecology of India vol. 64,6 (2014): 409-16. doi: https://doi.org/10.1007/s13224-014-0559-7
Pandit SN, Chauhan AR, Anagani M, Reddy S, Birla A, Ray SK. Multicenter Study of Contraceptive Vaginal Ring (NuvaRing(®)) in Normal Daily Practice in Indian Women. J Obstet Gynaecol India. 2014 Dec;64(6):409-16. doi: 10.1007/s13224-014-0559-7. Epub 2014 May 15. PMID: 25489144; PMCID: PMC4257921.
Copy Download .nbib Format: NLM
Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.

Journal of clinical and experimental hepatology

Duseja A, Singh SP, Saraswat VA, Acharya SK, Chawla YK, Chowdhury S, Dhiman RK, Jayakumar RV, Madan K, Misra SP, Mishra H, Modi SK, Muruganathan A, Saboo B, Sahay R, Upadhyay R.
PMID: 25941433
J Clin Exp Hepatol. 2015 Mar;5(1):51-68. doi: 10.1016/j.jceh.2015.02.006. Epub 2015 Mar 06.

Non-alcoholic fatty liver disease (NAFLD) is closely associated with metabolic syndrome. Prevalence of metabolic risk factors including diabetes mellitus, obesity, etc. is rapidly increasing in India putting this population at risk for NAFLD. Patients with NAFLD are at increased...

Cite
Duseja A, Singh SP, Saraswat VA, et al. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015;5(1):51-68doi: 10.1016/j.jceh.2015.02.006.
Duseja, A., Singh, S. P., Saraswat, V. A., Acharya, S. K., Chawla, Y. K., Chowdhury, S., Dhiman, R. K., Jayakumar, R. V., Madan, K., Misra, S. P., Mishra, H., Modi, S. K., Muruganathan, A., Saboo, B., Sahay, R., & Upadhyay, R. (2015). Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. Journal of clinical and experimental hepatology, 5(1), 51-68. https://doi.org/10.1016/j.jceh.2015.02.006
Duseja, Ajay, et al. "Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology." Journal of clinical and experimental hepatology vol. 5,1 (2015): 51-68. doi: https://doi.org/10.1016/j.jceh.2015.02.006
Duseja A, Singh SP, Saraswat VA, Acharya SK, Chawla YK, Chowdhury S, Dhiman RK, Jayakumar RV, Madan K, Misra SP, Mishra H, Modi SK, Muruganathan A, Saboo B, Sahay R, Upadhyay R. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015 Mar;5(1):51-68. doi: 10.1016/j.jceh.2015.02.006. Epub 2015 Mar 06. PMID: 25941433; PMCID: PMC4415196.
Copy Download .nbib Format: NLM
Multimode supercontinuum generation in chalcogenide glass fibres.

Optics express

Kubat I, Bang O.
PMID: 26906826
Opt Express. 2016 Feb 08;24(3):2513-26. doi: 10.1364/OE.24.002513.

Mid-infrared supercontinuum generation is considered in chalcogenide fibres when taking into account both polarisations and the necessary higher order modes. In particular we focus on high pulse energy supercontinuum generation with long pump pulses. The modeling indicates that when...

Cite
Kubat I, Bang O. Multimode supercontinuum generation in chalcogenide glass fibres. Opt Express. 2016;24(3):2513-26doi: 10.1364/OE.24.002513.
Kubat, I., & Bang, O. (2016). Multimode supercontinuum generation in chalcogenide glass fibres. Optics express, 24(3), 2513-26. https://doi.org/10.1364/OE.24.002513
Kubat, Irnis, and Bang, Ole. "Multimode supercontinuum generation in chalcogenide glass fibres." Optics express vol. 24,3 (2016): 2513-26. doi: https://doi.org/10.1364/OE.24.002513
Kubat I, Bang O. Multimode supercontinuum generation in chalcogenide glass fibres. Opt Express. 2016 Feb 08;24(3):2513-26. doi: 10.1364/OE.24.002513. PMID: 26906826.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 230 entries